Preponderant impact of the chemosensitivity assessed by the modeled CA-125 kinetic parameter KELIM on the success of the first line treatment: Pooled analysis of AGO-OVAR 7, AGO-OVAR 9 and ICON7 trials--a GINECO-GINEGEPS study

You, B, Tod, M, Leary, A et al. (12 more authors) (2020) Preponderant impact of the chemosensitivity assessed by the modeled CA-125 kinetic parameter KELIM on the success of the first line treatment: Pooled analysis of AGO-OVAR 7, AGO-OVAR 9 and ICON7 trials--a GINECO-GINEGEPS study. In: 51st Annual Meeting of the Society of Gynecologic Oncology, 28-31 Mar 2020, Toronto, Canada.

Metadata

Authors/Creators:
  • You, B
  • Tod, M
  • Leary, A
  • Ray-Coquard, I
  • Lortholary, A
  • Hardy-Bessard, AC
  • Perren, T ORCID logo https://orcid.org/0000-0001-8472-8856
  • Cook, A
  • Pfisterer, J
  • Bois, AD
  • Kurzeder, C
  • Burges, A
  • Peron, J
  • Freyer, G
  • Colomban, O
Dates:
  • Published: October 2020
Institution: The University of Leeds
Funding Information:
FunderGrant number
MRC (Medical Research Council) ExceptionsFAISAL AL-TERKAIT
Depositing User: Symplectic Publications
Date Deposited: 25 Jan 2021 14:32
Last Modified: 25 Jan 2021 14:32
Status: Published
Identification Number: https://doi.org/10.1016/j.ygyno.2020.05.627
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)